SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-025163
Filing Date
2020-09-15
Accepted
2020-09-15 20:06:48
Documents
2
Period of Report
2020-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1645
2 EX-24 DOCUMENT attachment1.htm EX-24 4356
  Complete submission text file 0000899243-20-025163.txt   7475
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Issuer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 220 MARLBOROUGH STREET #6 BOSTON MA 02116
Business Address
Gros David-Alexandre C (Reporting) CIK: 0001644489 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36620 | Film No.: 201177114